Clariant Ag · SIX:CLN
Clariant — H1 2020 Earnings Presentation
24 slides from Clariant's earnings presentation, Jul 30, 2020
Slide 1: First Half Year Results 2020
First Half Year Results 2020 30 JULY 2020
Slide 2: Disclaimer
2 First Half Year Results 2020 30 July 2020 Disclaimer This presentation contains certain statements that are the Company’s ability to continue to receive adequate neither reported financial results nor other historical products from its vendors on acceptable terms, or at all, information. and to co
Slide 3: First Half Year & Second Quarter 2020 – Highlights
3 First Half Year Results 2020 30 July 2020 First Half Year & Second Quarter 2020 – Highlights H1 2020 vs. H1 2019, figures from continuing operations Q2 2020 vs. Q2 2019, figures from continuing operations SALES 1 945 - 5 % SALES 926 -4% in CHF m in LC* y-o-y in CHF m in LC* y-o-y EBITDA 292 + 186
Slide 4: Sales Development & Mix
4 First Half Year Results 2020 30 July 2020 Sales Development & Mix All figures continuing operations − H1 2020 sales declined by 5 % in local H1 2020 SALES in CHF m currency and 13 % in Swiss francs due to an unfavorable currency impact of 8 % -6% 2 229 − Softer sales development in all Business Ar
Slide 5: Sales Distribution by Region
5 First Half Year Results 2020 30 July 2020 Sales Distribution by Region Emerging markets All figures continuing operations Mature markets − In H1 2020, sales increased in local currency in H1 2020 SALES CHF 1 945 m China and Latin America while Middle East & in CHF m Africa and total Asia remained
Slide 6: Care Chemicals
6 First Half Year Results 2020 30 July 2020 Care Chemicals H1 2020 H1 2019 % CHF % LC* − H1 2020 sales declined by 6 % in LC,* mainly impacted by Sales in CHF m 734 850 -14 % -6 % weak Aviation in Q1 2020 and lower demand for Industrial Applications amid COVID-19, while Consumer Care sales EBITDA in
Slide 7: Catalysis
7 First Half Year Results 2020 30 July 2020 Catalysis H1 2020 H1 2019 % CHF % LC* − H1 2020 sales declined by 4 % in LC* against a strong Sales in CHF m 392 432 -9 % -4 % comparison base; double-digit Petrochemicals growth could not fully compensate for weaker Syngas and Specialty EBITDA in CHF m 68
Slide 8: Natural Resources
8 First Half Year Results 2020 30 July 2020 Natural Resources H1 2020 H1 2019 % CHF % LC* − H1 2020 sales decreased by 5 % in LC* Sales in CHF m 819 947 -14 % -5 % − Sales in Oil & Mining Services (OMS) nearly reached EBITDA in CHF m 116 148 -22 % previous year’s level in LC as the result of a stron
Slide 9: First Half Year 2020 – EBITDA Development
9 First Half Year Results 2020 30 July 2020 First Half Year 2020 – EBITDA Development All figures continuing operations H1 EBITDA / margin − H1 2020 EBITDA declined to CHF 292 m in CHF m / in % of sales compared to an EBITDA of CHF 333 m in 350 14.9 % 15.0 % 16.1 % 300 14.1 % 2019, excluding the one
Slide 10: Second Quarter 2020 – EBITDA Development
10 First Half Year Results 2020 30 July 2020 Second Quarter 2020 – EBITDA Development All figures continuing operations Q2 EBITDA / margin − Q2 2020 EBITDA declined to CHF 135 m in CHF m / in % of sales from CHF 149 m in the previous year, excluding the CHF 231 m provision booked in 14.6 % 14.0 % 15
Slide 11: First Half Year 2020 – Net Result
11 First Half Year Results 2020 30 July 2020 First Half Year 2020 – Net Result All figures including discontinued operations NET RESULT − Net result for the Group increased to CHF 90 m in CHF m 100 versus CHF - 101 m in the first half of 2019 50 130 90 − Excluding the CHF 231 m provision booked in t
Slide 12: Outlook
a CLARIANT Outlook what is precious to you?
Slide 13: Improved EBITDA margin in challenging markets as COVID-19 impact is mitigated
13 First Half Year Results 2020 30 July 2020 Improved EBITDA margin in challenging markets as COVID-19 impact is mitigated and transformation program execution in motion − Sales declined by 5 % in LC* in H1 2020 and by 4 % in Q2 2020, impacted by the weaker demand environment amid the COVID-19 pande
Slide 14: Back-up Slides
a CLARIANT Back-up Slides what is precious to you?
Slide 15: A More Focused, High Value Specialty Portfolio
15 First Half Year Results 2020 30 July 2020 A More Focused, High Value Specialty Portfolio Continuing Operations: Sales growth Sales growth Sales growth expectation p.a. 5-7% expectation p.a. 6-9% expectation p.a. 5-7% EBITDA EBITDA EBITDA 19 - 21 % 26 - 30 % 18 - 20 % margin ambition margin ambiti
Slide 16: Discontinued Operations (Masterbatches and Pigments)
16 First Half Year Results 2020 30 July 2020 Discontinued Operations (Masterbatches and Pigments) H1 2020 H1 2019 % CHF % LC* − In H1 2020, sales decreased by 9 % in LC* and 15 % in Sales in CHF m 941 1 109 -15 % -9 % Swiss francs EBITDA in CHF m 67 91 -26 % − On a like-for-like basis (excl. Healthc
Slide 17: First Half Year 2020 – Sales and EBITDA by Business Area
17 First Half Year Results 2020 30 July 2020 First Half Year 2020 – Sales and EBITDA by Business Area Sales to 3rd parties EBITDA First Half Year in CHF m 2020 2019 % LC* 2020*** 2019 % CHF Care Chemicals 734 850 -6% 120 150 - 20 % margin 16.3 % 17.6 % Catalysis 392 432 -4% 68 84 - 19 % margin 17.3
Slide 18: Full Year 2019 – Sales and EBITDA by Business Area
18 First Half Year Results 2020 30 July 2020 Full Year 2019 – Sales and EBITDA by Business Area Sales to 3rd parties EBITDA Full Year in CHF m 2019 2018 % LC* 2019 2018 % CHF Care Chemicals 1 600 1 665 -1% 282 314 - 10 % margin 17.6 % 18.9 % Catalysis 925 861 +9% 212 185 + 15 % margin 22.9 % 21.5 %
Slide 19: First Half Year 2020 – Key Financials
19 First Half Year Results 2020 30 July 2020 First Half Year 2020 – Key Financials 2020 2019 Continuing operations CHF m % of sales CHF m % of sales Sales 1 945 100.0 % 2 229 100.0 % Local currency growth -5% 4% Organic growth* -5% 4% Acquisitions / divestitures 0% 0% Currencies -8% -4% Gross profit
Slide 20: First Half Year 2020 – Consolidated Statements of Cash Flows
20 First Half Year Results 2020 30 July 2020 First Half Year 2020 – Consolidated Statements of Cash Flows All figures including discontinued operations CHF m 2020 2019 Net result 90 - 101 Depreciation, amortization and impairment 138 184 Payments for restructuring - 11 - 16 Other 141 115 Cash flow b
Slide 21: Debt Maturity Profile as of 30 June 2020
21 First Half Year Results 2020 30 July 2020 Debt Maturity Profile as of 30 June 2020 LIQUIDITY FINANCIAL DEBT MATURITIES in CHF m in CHF m 1200 Derivatives 1000 21* Short-term loans, lease & other liabilities Certificate of indebtedness 800 CHF bond 600 Cash and short-term deposits 976 9 400 1 239
Slide 22: Update on COVID-19 mitigation measures
22 First Half Year Results 2020 30 July 2020 Update on COVID-19 mitigation measures • Employee safety – cases of infection kept low as a result of social distancing, home office arrangements and travel bans governed by Clariant’s GEM organization • Support for communities and stakeholders – distribu
Slide 23: Calendar of Upcoming Corporate Events
23 First Half Year Results 2020 30 July 2020 Calendar of Upcoming Corporate Events 29 October 2020 Nine Months 2020 Reporting 11 February 2021 Full Year 2020 Reporting 07 April 2021 Annual General Meeting
Slide 24: IR Contacts
24 First Half Year Results 2020 30 July 2020 IR Contacts Maria Ivek Phone: +41 61 469 63 73 Senior Investor Relations Officer Email: investor-relations@clariant.com Alexander Kamb Investor Relations Officer